BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Raoul JL, Adhoute X, Gilabert M, Edeline J. How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma. World J Hepatol 2016; 8(35): 1541-1546 [PMID: 28050234 DOI: 10.4254/wjh.v8.i35.1541]
URL: https://www.wjgnet.com/1948-5182/full/v8/i35/1541.htm
Number Citing Articles
Alice Boilève, Marc Hilmi, Matthieu Delaye, Annemilaï Tijeras-Raballand, Cindy Neuzillet. Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?Cancers 2021; 13(11): 2708 doi: 10.3390/cancers13112708
Jean-Luc Raoul, Masatoshi Kudo, Richard S. Finn, Julien Edeline, Maria Reig, Peter R. Galle. Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyondCancer Treatment Reviews 2018; 68: 16 doi: 10.1016/j.ctrv.2018.05.006
Cindy Neuzillet, Louis de Mestier, Benoît Rousseau, Olivier Mir, Mohamed Hebbar, Hemant M. Kocher, Philippe Ruszniewski, Christophe Tournigand. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumoursPharmacology & Therapeutics 2018; 181: 49 doi: 10.1016/j.pharmthera.2017.07.006
Jingyu Chen, Chien-Yu Chen, Christopher Nguyen, Lulu Chen, Kangmin Lee, Bangyan L. Stiles. Emerging signals regulating liver tumor initiating cellsLiver Research 2018; 2(2): 73 doi: 10.1016/j.livres.2018.08.003
Carolien M Beukhof, Leni van Doorn, Theo J Visser, Sander Bins, W Edward Visser, Ramona van Heerebeek, Folkert J van Kemenade, Yolanda B de Rijke, Wouter W de Herder, Layal Chaker, Ron H Mathijssen, Robin P Peeters. Sorafenib-Induced Changes in Thyroid Hormone Levels in Patients Treated for Hepatocellular CarcinomaThe Journal of Clinical Endocrinology & Metabolism 2017; 102(8): 2922 doi: 10.1210/jc.2016-4025
Cassia Regina Guedes Leal, Cristiane Magalhães, Daniel Barbosa, Diogo Aquino, Bernardo Carvalho, Elizabeth Balbi, Lucio Pacheco, Renata Perez, Paulo de Tarso Pinto, Sérgio Setubal. Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective studyInvestigational New Drugs 2018; 36(5): 911 doi: 10.1007/s10637-018-0621-x
Marc Hilmi, Cindy Neuzillet, Julien Calderaro, Fouad Lafdil, Jean-Michel Pawlotsky, Benoit Rousseau. Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directionsJournal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0824-5